Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 43, 2024 - Issue 3
148
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Pseudocholinesterase deficiency in ophthalmology: a systematic review

, &
Pages 429-437 | Received 18 Nov 2022, Accepted 03 Jan 2023, Published online: 20 Jan 2023

References

  • Trujillo R, West WP. Pseudocholinesterase Deficiency. In: StatPearls. Treasure Island, FL: StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC.; 2021.
  • Davis L, Britten JJ, Morgan M. Cholinesterase. Its significance in anaesthetic practice. Anaesthesia. 1997;52(3):244–260. doi:10.1111/j.1365-2044.1997.084-az0080.x.
  • Pierson DJ. How to read a case report (or teaching case of the month). Respir Care. 2009;54:1372–1378.
  • Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295–300. doi:10.1177/003591576505800503.
  • Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analysis . The Ottawa Health Research Institute; 2022. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  • Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60–63. doi:10.1136/bmjebm-2017-110853.
  • Bazerbachi F, Sawas T, Vargas EJ, Prokop LJ, Chari ST, Gleeson FC. Metal stents versus plastic stents for the management of pancreatic walled-off necrosis: a systematic review and meta-analysis. Gastrointest Endosc. 2018;87(1):30–42.e15. doi:10.1016/j.gie.2017.08.025.
  • Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128(1):305–310. doi:10.1097/PRS.0b013e318219c171.
  • Spiers F, Juul P. Cholinesterase activity in plasma and erythrocytes. a clinico-haematological study based on normal subjects and on patients with glaucoma, of whom some not treated with and some treated with anticholinesterases. Acta Ophthalmol (Copenh). 1964;42(3):696–712. doi:10.1111/j.1755-3768.1964.tb00921.x.
  • Ben-Dor D, Weisenberg E. The effect of phospholine iodide eye drops on blood cholinesterase in glaucoma patients. Isr J Med Sci. 1966;2:624–625.
  • Eilderton TE, Farmati O, Zsigmond EK. Reduction in plasma cholinesterase levels after prolonged administration of echothiophate iodide eyedrops. Can Anaesth Soc J. 1968;15(3):291–296. doi:10.1007/bf03008742.
  • Chessen DH, Geha DG, Salzman C. ECT, glaucoma, and prolonged apnea. Dis Nerv Syst. 1974;35:152–153.
  • Demayo AP, Reidenberg MM. Grand mal seizure in a child 30 minutes after cyclogyl (cyclopentolate hydrochloride) and 10% neo-synephrine (phenylephrine hydrochloride) eye drops were instilled. Pediatrics. 2004;113(5):e499–500. doi:10.1542/peds.113.5.e499.
  • Gesztes T. Prolonged apnoea after suxamethonium injection associated with eye drops containing an anticholinesterase agent. Br J Anaesth. 1966;38(5):408–409. doi:10.1093/bja/38.5.408.
  • Hains J. Glaucoma associated with suxamethonium apnoea. Anaesthesia. 1968;23(3):438–439. doi:10.1111/j.1365-2044.1968.tb00087.x.
  • Kramer LP. Eye drops and apnea. Can Med Assoc J. 1982;127:1078–1079.
  • Manoguerra A, Whitney C, Clark RF, Anderson B, Turchen S. Cholinergic toxicity resulting from ocular instillation of echothiophate iodide eye drops. J Toxicol Clin Toxicol. 1995;33(5):463–465. doi:10.3109/15563659509013755.
  • Markman HD, Rosenberg P, Dettbarn WD. Eye drops and diarrhea. Diarrhea as the first symptom of echothiophate iodide toxicity. N Engl J Med. 1964;271(4):197–198. doi:10.1056/nejm196407232710408.
  • Messer GJ, Stoudemire A, Knos G, Johnson GC. Electroconvulsive therapy and the chronic use of pseudocholinesterase-inhibitor (echothiophate iodide) eye drops for glaucoma. A case report. Gen Hosp Psychiatry. 1992;14(1):56–60. doi:10.1016/0163-8343(92)90026-7.
  • Nelson LB, Wagner RS, Harley RD. Prolonged apnea caused by inherited cholinesterase deficiency after strabismus surgery. Am J Ophthalmol. 1983;96(3):392–393. doi:10.1016/s0002-9394(14)77835-3.
  • Ozcan S, İ̇nan N, Kaymak C. Postoperative prolonged apnea in weill marchesani syndrome. Gazi Medical J. 2003;14:93–95.
  • Packman PM, Meyer DA, Verdun RM. Hazards of succinylcholine administration during electrotherapy. Arch Gen Psychiatry. 1978;35(9):1137–1141. doi:10.1001/archpsyc.1978.01770330111011.
  • Pantuck EJ. Ecothiopate iodide eye drops and prolonged response to suxamethonium. Br J Anaesth. 1966;38(5):406–407. doi:10.1093/bja/38.5.406.
  • Shammas HF, Tabbara KF, der Kaloustian VM. Atypical serum cholinesterase in a family with congenital distichiasis. J Med Genet. 1976;13(6):514–515. doi:10.1136/jmg.13.6.514.
  • Wood JR, Anderson RL, Edwards JJ. Phospholine iodide toxicity and Jones’ tubes. Ophthalmology. 1980;87(4):346–349. doi:10.1016/s0161-6420(80)35230-5.
  • McGavi DD. Depressed levels of serum-pseudocholinesterase with ecothiophate-iodide eyedrops. Lancet. 1965;2(7406):272–273. doi:10.1016/s0140-6736(65)92391-3.
  • Tuovinen E, Esila R, Liesmaa M. Topically administered demekastigmine bromide as a cholinesterase inhibitor 1. Acta Ophthalmol. 1966;44(4):676–683. doi:10.1111/j.1755-3768.1966.tb08087.x.
  • MacQueen J, Plaut D, Borges J, Anido G. Manual colorimetric methods for pseudocholinesterase and red cell (true) cholinesterase. Clin Chem. 1971;17(6):481–485. doi:10.1093/clinchem/17.6.481.
  • Panhuizen IF, Snoeck MM, Levano S, Girard T. Prolonged neuromuscular blockade following succinylcholine administration to a patient with a reduced butyrylcholinesterase activity. Case Rep Med. 2010;2010:472389. doi:10.1155/2010/472389.
  • Schmidt KG, Horowitz Y, Buckman G, Segev E, Levinger E, Geyer O. Lowering of IOP by echothiophate iodide in pseudophakic eyes with glaucoma. Curr Eye Res. 2010;35(8):698–702. doi:10.3109/02713681003794076.
  • Kraus CL, Trivedi RH, Wilson ME. Intraocular pressure control with echothiophate iodide in children’s eyes with glaucoma after cataract extraction. J AAPOS. 2015;19(2):116–8.e1. doi:10.1016/j.jaapos.2014.11.006.
  • Soliday FK, Conley YP, Henker R. Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired, and drug influences. Aana J. 2010;78:313–320.
  • Thomsen JL, Nielsen CV, Palmqvist DF, Gätke MR. Premature awakening and underuse of neuromuscular monitoring in a registry of patients with butyrylcholinesterase deficiency. Br J Anaesth. 2015;115 Suppl 1:i89–94. doi:10.1093/bja/aev103.
  • Østergaard D, Viby-Mogensen J, Rasmussen SN, Gätke MR, Pedersen NA, Skovgaard LT. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA). Acta Anaesthesiol Scand. 2003;47(10):1219–1225. doi:10.1046/j.1399-6576.2003.00243.x.
  • Thomsen JL, Nielsen CV, Eskildsen KZ, Demant MN, Gätke MR. Awareness during emergence from anaesthesia: significance of neuromuscular monitoring in patients with butyrylcholinesterase deficiency. Br J Anaesth. 2015;115 Suppl 1:i78–88. doi:10.1093/bja/aev096.
  • Schuh FT. Pseudocholinesterase activity of human whole blood, bank blood, and blood protein solutions. Anaesthesist. 1975;24:103–106.
  • Smith DC, Ridley SA, Donaldson KF. Fresh frozen plasma and edrophonium in a patient with a plasma cholinesterase deficiency. Anaesthesia. 1993;48(6):511–513. doi:10.1111/j.1365-2044.1993.tb07073.x.
  • Gill RS, O’Connell N, Scott RP. Reversal of prolonged suxamethonium apnoea with fresh frozen plasma in a 6-week-old infant. Anaesthesia. 1991;46(12):1036–1038. doi:10.1111/j.1365-2044.1991.tb09917.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.